Literature DB >> 16618710

The DNA damage response arouses the immune system.

Stephan Gasser1, David H Raulet.   

Abstract

Although there is considerable knowledge of how DNA damage triggers cell cycle arrest, DNA repair, and apoptosis, little was known about its potential role in immune responses. Recently, we showed that genotoxic stress and stalled DNA replication forks induce the expression of ligands for the NKG2D receptor found in natural killer cells and certain T cells, cell types that are able to attack tumor cells. Chronic activation of this response in tumor cells may contribute to immune recognition, but it also imposes a selection mechanism for immune escape and malignant progression. This unique arm of the DNA damage response may have implications for understanding therapeutic responses, many of which induce the DNA damage response, and for designing more effective regimens to treat cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618710     DOI: 10.1158/0008-5472.CAN-05-4603

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  71 in total

1.  APOBEC3 proteins and genomic stability: the high cost of a good defense.

Authors:  Iñigo Narvaiza; Sébastien Landry; Matthew D Weitzman
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

Review 2.  Vaccines targeting cancer stem cells: are they within reach?

Authors:  Madhav V Dhodapkar; Kavita M Dhodapkar
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

3.  Viral and Cellular Genomes Activate Distinct DNA Damage Responses.

Authors:  Govind A Shah; Clodagh C O'Shea
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

Review 4.  Regulation of innate immunity by signaling pathways emerging from the endoplasmic reticulum.

Authors:  Fabio Martinon; Laurie H Glimcher
Journal:  Curr Opin Immunol       Date:  2010-11-18       Impact factor: 7.486

Review 5.  Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors.

Authors:  H J Symons; E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2008-08-04       Impact factor: 5.483

Review 6.  Immune surveillance of unhealthy cells by natural killer cells.

Authors:  Alexandre Iannello; David H Raulet
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2013-10-17

7.  Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells.

Authors:  Ulrich Langenkamp; Uwe Siegler; Simon Jörger; Stefan Diermayr; Alois Gratwohl; Christian P Kalberer; Aleksandra Wodnar-Filipowicz
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

8.  Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusion.

Authors:  Alexander Filatenkov; Jeanette Baker; Antonia M Müller; G-One Ahn; Holbrook Kohrt; Suparna Dutt; Kent Jensen; Sussan Dejbakhsh-Jones; Robert S Negrin; Judith A Shizuru; Edgar G Engleman; Samuel Strober
Journal:  Radiat Res       Date:  2014-07-03       Impact factor: 2.841

9.  Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18.

Authors:  Ioannis Alagkiozidis; Andrea Facciabene; Carmine Carpenito; Fabian Benencia; Zdenka Jonak; Sarah Adams; Richard G Carroll; Phyllis A Gimotty; Rachel Hammond; Gwen-äel Danet-Desnoyers; Carl H June; Daniel J Powell; George Coukos
Journal:  J Transl Med       Date:  2009-12-10       Impact factor: 5.531

10.  Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms.

Authors:  Masahisa Jinushi; Marimo Sato; Akira Kanamoto; Akihiko Itoh; Shigenori Nagai; Shigeo Koyasu; Glenn Dranoff; Hideaki Tahara
Journal:  J Exp Med       Date:  2009-05-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.